丹麦酒精性肝硬化门诊患者的肝细胞癌风险
这项全国性登记历史队列研究纳入2006至2018年丹麦4553例酒精性肝硬化门诊患者,描述肝细胞癌(HCC)累积风险及死因。HCC累积风险1年0.9%、5年3.6%、10年6.0%,约每年0.7%;男性、高龄和失代偿肝硬化预测更高HCC风险。10年后6.9%死亡归因于HCC,6.5%归因于静脉曲张出血,5.0%归因于创伤。
要点
- 丹麦酒精性肝硬化门诊患者HCC累积风险1年0.9%、5年3.6%、10年6.0%,约每年0.7%。
- 男性、高龄和失代偿肝硬化预测更高的HCC风险。
- 10年后死亡归因:HCC 6.9%、静脉曲张出血6.5%、创伤5.0%。
核心结论
- 2006至2018年丹麦酒精性肝硬化门诊患者HCC风险约为每年0.7%,死于静脉曲张出血或创伤的可能性与死于HCC接近。
- 作者认为通过监测每发现一例HCC需进行许多可能有害的检查,针对预防其他死因的干预可能更具成本效益。
研究设计与样本
- 全国性、基于登记的历史队列研究,纳入2006至2018年所有丹麦酒精性肝硬化门诊患者,排除癌症、慢性病毒性肝炎或自身免疫性肝病及80岁以上者,随访至2018年。
- 共纳入4553例患者。
主要发现
- 4553例中181例发生HCC,2274例死亡。
- HCC累积风险1年0.9%(95%CI 0.7-1.3)、5年3.6%(95%CI 3.0-4.2)、10年6.0%(95%CI 5.1-7.0),约每年0.7%。
- 男性、高龄和失代偿肝硬化预测更高的HCC风险。
- 10年后队列死亡中6.9%归因于HCC,6.5%归因于静脉曲张出血,5.0%归因于创伤。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Accurate estimates of hepatocellular carcinoma (HCC) risk in patients with cirrhosis are important to guide surveillance strategies. We described HCC risk among outpatients with alcohol-related cirrhosis and contrasted the risk of death from HCC with the risk of death from variceal bleeding or trauma. METHODS: This was a nationwide, registry-based historical cohort study between 2006 and 2018. We included all Danish outpatients with a hospital diagnosis of alcohol-related cirrhosis, except those with cancer, those with chronic viral hepatitis or autoimmune liver disease, and those older than 80 years. We followed them through 2018 and described the cumulative risk of HCC and the cumulative risk of death from HCC, variceal bleeding, or trauma. RESULTS: Of the 4,553 patients included, 181 developed HCC and 2,274 died. The cumulative risk of HCC was 0.9% (95% CI 0.7-1.3) after 1 year, 3.6% (95% CI 3.0-4.2) after 5 years, and 6.0% (95% CI 5.1-7.0) after 10 years, or approximately 0.7% per year. Male sex, older age, and decompensated cirrhosis predicted a higher HCC risk. After 10 years, 6.9% of deaths in the cohort could be attributed to HCC, whereas 6.5% could be attributed to variceal bleeding, and 5.0% to trauma. CONCLUSIONS: In 2006-2018, Danish outpatients with alcohol-related cirrhosis had an HCC risk of 0.7% per year, and they were nearly as likely to die from variceal bleeding or from trauma as from HCC. The implications are that many potentially harmful examinations are required for every HCC found through surveillance, so interventions targeting the prevention of other causes of death might be more cost-effective. LAY SUMMARY: We described the risk of hepatocellular carcinoma (HCC, the most common form of liver cancer originating in the liver) in Danish outpatients with cirrhosis due to harmful alcohol consumption. Accurate data on that risk are important for patient counselling and decisions about screening for HCC. The risk was about 0.7% per year, which is lower than might be expected and suggests that many potentially harmful screening examinations are required for every HCC found through surveillance.
引用
- Jepsen P, Kraglund F, West J, et al. Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis. J Hepatol. 2020. PMID: 32512015. doi:10.1016/j.jhep.2020.05.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。